Today in Peak History (June 1-10)
Release time:
2020-08-14
peak (6# March 1 - 10 )
1988
◆ 1993 6 8 , Zhejiang Jianfeng Communication Cable Company laid the foundation and started construction.
◆ 1995 6 March 3 to 4 , a Shanghai joint press corps composed of 14 news units including China Enterprise News, Economic Daily, Science and Technology Daily, China Securities News, Financial Times, Hong Kong China Merchants Guide, etc. visited Jianfeng Group Company.
◆ 1998 6 , Zhejiang Jianfeng Haizhou Pharmaceutical Company was approved by the Ministry of Foreign Trade and Economic Cooperation and obtained the right to import and export on its own.
◆ 2003 6 6 , Jianfeng Dengcheng Cement Project officially started construction in Fuyang, which is also the first cement production project for Jianfeng Cement to leave Jinqu Basin.
◆ 2006 6# In February, the 7th board of directors of the 6th Jianfeng Group deliberated and approved the shutdown proposal of the cement machine vertical kiln production line. With the help of the Jinhua municipal government steering group, the three vertical kiln production lines of Jinhua Cement Plant were successfully shut down and all the employees of the plant were properly placed.
2012 6 September , Jianfeng Pharmaceutical signed a letter of intent for strategic cooperation between hospitals and enterprises with Jinhua Municipal People's Hospital (affiliated hospital of Jinhua Vocational and Technical College). ◆
6 August 6 , the "peak pharmaceutical class" of the school of pharmacy and materials engineering of Jinhua vocational and technical college held a class opening ceremony. peak pharmaceutical cooperated with the school of pharmacy and materials engineering of the golden vocational college to carry out personnel orientation training. Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, personally went to the Golden Vocational College for an interview, and selected more than ,40 students from the registered students to form a "peak class". ◆
6 September 5 , Jianfeng Group's first issue of 3 .3 billion yuan corporate bonds was successfully issued with a deadline of 5 and a coupon rate of 4.9% . ◆
6 , Tianjin Jianfeng Natural Products Company ranked among the top 20 in Tianjin Development Zone Science and Technology Innovation . ◆
June 11 March, Yunnan Jianfeng Cement Company was awarded the title of "2016 Key Leading Enterprise in Pu 'er City. ◆ 2017
6# December, Peak Health Technology Company was awarded the "Demonstration Factory" award by Yangtze River Delta Nutrition and Health Industry Alliance. (Xu Xia finishing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page